Maynard Um
-
-
-
-
-
-
-
Regeneron Pharma (REGN) PT Raised to $975 at Guggenheim
-
-
-
-
-
-
-
Regeneron (REGN) Tops Q4 EPS by 92c
-
-
-
-
-
-
-
4Q25/2026 Biotech Earnings Preview: RBC
-
-
-
-
-
-
-
Regeneron Pharma (REGN) PT Raised to $873 at Leerink Partners
-
-
-
-
-
-
-
Regeneron and Tessera partner on gene editing therapy for rare disease
-
-
-
-
-
-
-
Regeneron Pharma (REGN) PT Raised to $800 at Raymond James
-
-
-
-
-
-
-
Regeneron Pharma (REGN) PT Raised to $740 at Cantor Fitzgerald
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

